Two new clinical trials at MD Anderson are taking aim at mantle cell
lymphoma – a rare form of non-Hodgkin’s lymphoma.
Most mantle cell lymphoma trials test new treatments on patients
with relapsed disease, but MD Anderson’s trials are focusing on
patients who are newly diagnosed.
“The first therapy is the most important,” said Michael Wang, M.D.,
professor of Lymphoma and Myeloma and the trial’s principal investigator....